Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples